US EditionSwiss Leaders Seek Talks With Roche, Novartis After US Tariffs
SWITZERLAND, AUG 10 – Roche and Novartis shift production to the U.S. to avoid 39% tariffs on Swiss imports imposed by the Trump administration, impacting Swiss-U.S. trade relations.
- On August 10, 2025, Switzerland’s government reached out to Roche Holding AG and Novartis AG to discuss the tariff situation after the country was hit with the highest US levies.
- On April 2, President Donald Trump announced reciprocal tariffs on nearly all U.S. trading partners, and Swiss President Karin Keller-Sutter traveled to the U.S. on Monday but left without a deal.
- The Swiss Federal Council said 39% tariffs are impacting Swiss exports entering the U.S. and remains committed to discussions to reduce these tariffs swiftly.
- Calling a crisis summit, Economy Minister Guy Parmelin and Interior Minister Elisabeth Baume-Schneider will meet top executives, as Trump warned sector measures soon, despite pharmaceuticals remaining exempt.
- Last week, appellate court judges scrutinized Trump’s tariff authority, and with the government recess ending on Wednesday, a gathering could occur as early as this month.
11 Articles
11 Articles
Swiss Leaders Seek Roche, Novartis Talks Amid US Tariffs
(Bloomberg) -- Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation, a spokesperson said, after the country was hit with the highest US levies in the developed world.
As U.S. Tariffs Take Effect, Foreign Leaders Seek Exemptions
(Just The News)—As leaders worldwide prepare to face President Donald Trump’s import taxes, many are seeking exemptions for key industries and products, something Trump initially said he wouldn’t grant. The diplomatic efforts show foreign leaders are eager for carveouts and workarounds after Trump’s tariffs on products from 66 nations, the 27-nation European Union, and others took effect. Many leaders want better terms – or at least exemptions. …
Swiss Leaders Seek Talks With Roche, Novartis After US Tariffs
Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation, a spokesperson said, after the country was hit with the highest US levies in the developed world.
The two Swiss pharmaceutical companies are already preparing for the threatening tariffs, as the "NZZ on Sunday" writes.
Trump's tariff threats have an impact: Roche and Novartis will in future produce the most drugs for the US in America, which means jobs in Switzerland.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
